Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 543.3B | 1.4T | 877.5B | 906.1B |
Cost of revenue | 489.6B | 1.3T | 803.9B | 837.0B |
Gross profit | 53.7B | 129.2B | 73.6B | 69.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 7.2B | 8.9B | 9.7B | 5.9B |
Other operating expenses | — | — | — | — |
Operating income | 12.6B | 98.7B | 43.7B | 40.5B |
Non operating interest income | ||||
Income | 1.6B | 1.5B | 2.4B | 3.2B |
Expense | 7.8B | 8.2B | 2.9B | 7.8B |
Other income expense | — | — | — | — |
Pretax income | 322.5M | 20.8B | 28.5B | 14.2B |
Tax provision | 0 | 0 | 0 | 0 |
Net income | 322.5M | 20.8B | 28.5B | 14.2B |
Basic EPS | 0.0 | — | — | — |
Diluted EPS | 0.0 | — | — | — |
Basic average shares | 9.6B | — | — | — |
Diluted average shares | 9.6B | — | — | — |
EBITDA | 16.7B | 56.0B | 32.2B | 24.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | 20.3M | -69.0M | 0 | -2.7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |